U.S. markets close in 5 hours 13 minutes

Sinovac Biotech Ltd. (SVA)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
6.470.00 (0.00%)
As of 3:43PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close6.47
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's Range6.47 - 6.47
52 Week Range6.47 - 6.47
VolumeN/A
Avg. Volume0
Market Cap642.437M
Beta (5Y Monthly)0.05
PE Ratio (TTM)6.66
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
98% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Indonesia Becomes Second in Asia to Hit 100,000 Covid Deaths
    Bloomberg

    Indonesia Becomes Second in Asia to Hit 100,000 Covid Deaths

    (Bloomberg) -- Indonesia has reached a grim milestone as more than 100,000 people died from the coronavirus, becoming the second country in Asia to breach that threshold.After weeks of topping the world’s tally of daily Covid-19 deaths, Southeast Asia’s largest economy added 1,747 fatalities on Wednesday, according to data from the health ministry, bringing its total number to 100,636.Indonesia joins 11 other countries -- including Brazil and India -- that have lost more than 100,000 lives in th

  • Reuters

    Botswana pays equivalent of $15 a dose for Sinovac's COVID-19 vaccine

    Botswana's health minister said on Friday that the government was paying the equivalent of $15 a dose for the COVID-19 vaccine developed by China's Sinovac Biotech and almost $29 a dose for U.S. company Moderna's shot. African countries have struggled to procure enough vaccines in the global scramble for doses, with coverage secured through World Health Organization (WHO) and African Union (AU)-backed schemes so far falling short of the continent's needs. Under pressure over a recent spike in COVID-19 infections, health minister Edwin Dikoloti revealed how much the diamond-rich southern African country was paying in bilateral deals with pharmaceutical companies Sinovac, Moderna and India's Bharat Biotech.

  • Reuters

    UPDATE 2-Antibodies from Sinovac's COVID-19 shot fade after about 6 months, booster helps - study

    Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed. Chinese researchers reported the findings from a study of blood samples from healthy adults aged between 18-59 in a paper published on Sunday, which has not been peer reviewed. Among participants who received two doses, two or four weeks apart, only 16.9% and 35.2% respectively still had neutralising antibodies above what researchers regard as a detectable threshold level six months after the second shot, the paper said.